Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough?

Background: The prevalence of high-density lipoprotein cholesterol (HDL-C) in patients who have achieved low-density lipoprotein cholesterol (LDL-C) targets in the current era of universal statin therapy remains unknown. We conducted a study to determine the prevalence of low HDL-C in patients with documented coronary artery disease, and to determine the lipid-lowering treatment patterns in secondary prevention of coronary artery disease.

Methods: In this retrospective cohort analysis, data were obtained from the electronic database of a cardiology clinic.